GLOBAL BENIGN PROSTATIC HYPERPLASIA SURGICAL DEVICES MARKET ANALYSIS INDUSTRY INSIGHTS, TRENDS, OUTLOOK, AND OPPORTUNITY ANALYSIS, 2020–2027
© Coherent market Insights. All Rights Reserved
REPORT DESCRIPTION Benign Prostatic Hyperplasia Surgical Devices - Overview
The global benign prostatic hyperplasia surgical devices market, which accounted for around US$ 375.9 million in 2016, is now foreseen to exhibit a CAGR of 7.5% over the forecast period (2017-2025). With the emergence of minimally invasive therapies, such as implants, transurethral needle ablation (TUNA), and prostatic artery embolization (PAE), the global patient pool is expected to increase dramatically, which would inadvertently bolster the growth of the global benign prostatic surgical devices market over the projected period. The lucrative global market has apparently witnessed a multitude of mergers, acquisitions, and product launches in the recent past. Various companies, ranging from the leading medical device manufacturers, such as Medtronic Plc, Boston Scientific Corporation and Olympus Corporation, to the new startups, such as NeoTract, Inc., and ProArc Medical, show major involvement in these business growth activities. Browse Research Reports: https://www.coherentmarketinsights.com/market-insight/benign-prostatichyperplasia-surgical-devices-market-1199 Š Coherent market Insights. All Rights Reserved
REPORT DESCRIPTION In 2011, Urologix, Inc. and Medtronic Plc struck a deal, as a part of which Urologix, Inc., received license for Prostiva. In 2016, after defaulting on a debt to be paid to Medtronic Plc, Urologix sold its assets to a private buyer. Furthermore, in 2015, Boston Scientific Corporation acquired the male urology portfolio of American Medical Systems, which had generated over US$ 100 million in the last few years from devices sold for the treatment of benign prostatic hyperplasia. NoeTract, Inc. received the CE approval for its product, called UroLift Systems, in 2010, and further went on to receive the de novo 510(k) approval from the U.S. FDA in 2013. In June 2017, Merit Medical Systems, Inc. manufacturer of disposable devices received FDA approval for benign prostatic hyperplasia for its product, Embosphere Microspheres. Furthermore, in May 2017, NxThera, Inc., a radiofrequency devices manufacturer, announced that the product, RezÅ«m System has been used to treat more than 10,000 patients suffering from the disease across the U.S. and Europe. Request a Sample copy of this reports :https://www.coherentmarketinsights.com/insight/request-sample/1199 © Coherent market Insights. All Rights Reserved
REPORT DESCRIPTION Key Market Takeaways: •Burgeoning adoption of minimally invasive therapies, such as implants, in some of the developed economies of the world, including the U.S., Germany, and the U.K., tremendously boosts the global benign prostatic hyperplasia surgical devices market expansion. •Ambulatory surgery centers is expected to be the prime destination for people suffering from benign prostatic hyperplasia due to the development of minimally invasive therapies, which do not require hospitalization of the patients. •The North America benign prostatic hyperplasia surgical devices market is projected to dominate the global market over the forecast timeline, due to the high adoption rate of innovative products, such as radiofrequency devices, implants, and others, in the region.
•The major players operating in the global benign prostatic hyperplasia surgical devices market include Olympus Corporation, Boston Scientific Corporation, Medifocus Inc., KARL STORZ SE & Co. KG, NxThera, Inc., ProArc Medical, Lisa Laser Products OHG, and Richard Wolf Gmbh. Buy-Now this Research Report @
https://www.coherentmarketinsights.com/insight/buy-now/1199 © Coherent market Insights. All Rights Reserved
ABOUT COHERENT MARKET INSIGHTS ABOUT US Coherent Market Insights is a global market intelligence and consulting organization focused on assisting its plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, with an office at the global financial capital in the U.S. Our client base includes players from across all business verticals in over 150 countries worldwide. We are uniquely positioned to help businesses around the globe deliver practical and lasting results through various recommendations about operational improvements, technologies, emerging market trends and new working methods. We offer both customized and syndicated market research reports that help our clients create visionary growth plans to provide traction to their business. We meticulously study emerging trends across various industries at both the global and regional levels to identify new opportunities for our clientele.
SERVICES INDUSTRY ANALYSIS
CUSTOMIZED RESEARCH
SYNDICATED RESEARCH
MARKET INTELLIGENCE SERVICES
CONSULT STUDIES
COUNTRY SPECIFIC STUDIES
Š Coherent market Insights. All Rights Reserved
ABOUT CMI SECTOR COVERAGE
BIOTECHNOLOGY
CLINICAL DIAGNOSTIC
HEALTHCARE IT
MEDICAL DEVICES
MEDICAL IMAGING
PHARMACEUTICAL
OUR CLIENTS
Global Leading Equipment and System Manufacturers Marketing Consultancies and the Advertising Industry Component Providers and System Integrators
Private and Government organization
Distributors, Retailors and Value Added Resellers
Outsourcing Companies
Healthcare IT Solutions Developers
Universities and Business Schools.
© Coherent market Insights. All Rights Reserved
KEY STATS
RESEARCH SOLUTIONS
100+
FEASIBILITY STUDIES
Insights Published Per Year
GLOBAL REPORTS
150+
Consulting Projects Till Date
COUNTRY ANALYSIS CONSULT PROJECTS
125+
Clients Worldwide Per Year
110+
SURVEY RESEARCH
EXCEL FORECAST DATABASE
CUSTOMIZED SOLUTIONS
COMPETITIVE ASSESSMENT TECHNOLOGY SNIPPETS
Analysts and Contract Consultants
Coherent Market Insights excels at offering unmatched actionable market intelligence across various industry verticals, including chemicals, healthcare, and food & beverages, to name a few. We implement holistic market research methodology in order to result in the best possible market research reports across various industries worldwide. Based on our unmatched expertise across various industries—no matter how large or small, how complex or unique—we help our clients achieve better outcomes with uniquely designed and highly customized solutions. Our coverage includes insights that help our clients ensure sustained growth in developed markets and also key inputs to help them tap into emerging markets and exploit the plethora of opportunities posed therein. © Coherent market Insights. All Rights Reserved
THANK YOU To know more about us, visit our website: www.coherentmarketinsights.com For sales queries or new topics email us on: sales@coherentmarketinsights.com For other queries contact: Mr. Shah (Manager - Business Development) Coherent Market Insights sales@coherentmarketinsights.com +1-206-701-6702
Š Coherent market Insights. All Rights Reserved